aap without one-time effects, sales of the first half of 2009 are
slightly below previous year's>
aap without one-time effects, sales of the first half of 2009 are slightly below previous year's
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ aap Implantate AG, a medical technology company listed on theFrankfurt Stock Exchange in the Prime Standard segment achieved inthe first six months of the financial year 2009 - according topreliminary figures - sales of EUR 14.7 million (-10% to the firsthalf of 2008).Both periods still contain one-time effects. In the previous year,within an initial order from a global partner, we registered ordersto the amount of EUR 1.6 million. In March 2009 we were able to sella product that does not belong anymore to the core business in theamount of EUR 0.5 million. Without the consideration of these notre-occurring revenues, the sales of the first half of 2009 decreasedslightly by 3%.Within the cost reduction program, further measures were carried outin the second quarter. These measures should show first effects onthe company's performance during the current financial year.For the second half of 2009, aap expects a recovery of the demand andalong with the interest of global partner companies in aap's research& development projects, improvements on the sales and revenue side.The publication of the full aap Implantate AG six month report 2009is scheduled for August 17, 2009._______________________aap is a medical technology company that develops, manufactures andmarkets biomaterials and implants for trauma and orthopaedics. Itsproduct portfolio includes bone cements, bone graft substitutes,antibiotic carriers, and implants for fracture healing and jointreplacement. In addition to its Berlin headquarters the company haslocations in Dieburg and Obernburg near Frankfurt am Main as well asat Nijmegen in the Netherlands. aap Implantate AG has been listed inthe Prime Standard segment at the Frankfurt stock exchange since May16, 2003.Please address any queries to:aap Implantate AG, Nanette Hüdepohl, Head of CorporateCommunications, Lorenzweg 5, 12099 Berlin, GermanyTel.: +49 30 7501 9133; Fax: +49 30 7501 9290; n.huedepohl(at)aap.deFor further information about aap bio implants, visitwww.aap-bioimplants.com --- End of Message ---aap Implantate AGLorenzweg 5 Berlin GermanyWKN: 506660; ISIN: DE0005066609; Index: CDAX, Prime All Share, TECH All Share;Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Regulierter Markt in Frankfurter Wertpapierbörse;
Bereitgestellt von Benutzer: hugin
" alt="Rule 8.3 AXA IM UK LTD: FIRST GROUP Plc>">
Datum: 16.07.2009 - 12:23 Uhr
Sprache: Deutsch
News-ID 3645
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 246 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"aap without one-time effects, sales of the first half of 2009 are
slightly below previous year's>"
steht unter der journalistisch-redaktionellen Verantwortung von
aap Implantate AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
